Erythropoietin prevents necrotizing enterocolitis in very preterm infants: a randomized controlled trial

BACKGROUND: Necrotizing enterocolitis (NEC) is one of the most severe complications in very preterm infants, but there are currently no accepted methods to prevent NEC. Studies have shown that erythropoietin (EPO) has the potential to prevent NEC or improve outcomes of preterm NEC. This study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yong, Song, Juan, Sun, Huiqing, Xu, Falin, Li, Kenan, Nie, Chunxia, Zhang, Xiaoli, Peng, Xirui, Xia, Lei, Shen, Ziyun, Yuan, Xiao, Zhang, Shan, Ding, Xue, Zhang, Yaodong, Kang, Wenqing, Qian, Liling, Zhou, Wenhao, Wang, Xiaoyang, Cheng, Xiuyong, Zhu, Changlian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414749/
https://www.ncbi.nlm.nih.gov/pubmed/32771013
http://dx.doi.org/10.1186/s12967-020-02459-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414749/
https://www.ncbi.nlm.nih.gov/pubmed/32771013
http://dx.doi.org/10.1186/s12967-020-02459-w

Ejemplares similares